Document Detail

A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression.
MedLine Citation:
PMID:  22244827     Owner:  NLM     Status:  Publisher    
Oncolytic viruses engineered to replicate in tumour cells but not in normal cells could be used as tumour-specific vectors carrying the therapeutic genes. We previously developed a telomerase-specific oncolytic adenovirus, OBP-301, that causes cell death in human cancer cells with telomerase activities. Here, we further modified OBP-301 to express the wild-type p53 tumour suppressor gene (OBP-702), and investigated whether OBP-702 induces stronger antitumour activity than OBP-301. The antitumour effect of OBP-702 was compared to that of OBP-301 on OBP-301-sensitive (H358 and H460) and OBP-301-resistant (T.Tn and HSC4) human cancer cells. OBP-702 suppressed the viability of both OBP-301-sensitive and OBP-301-resistant cancer cells more efficiently than OBP-301. OBP-702 caused increased apoptosis compared to OBP-301 or a replication-deficient adenovirus expressing the p53 gene (Ad-p53) in H358 and T.Tn cells. Adenovirus E1A-mediated p21 and MDM2 downregulation was involved in the apoptosis caused by OBP-702. Moreover, OBP-702 significantly suppressed tumour growth in subcutaneous tumour xenograft models compared to monotherapy with OBP-301 or Ad-p53. Our data demonstrated that OBP-702 infection expressed adenovirus E1A and then inhibited p21 and MDM2 expression, which in turn efficiently induced apoptotic cell death. This novel apoptotic mechanism suggests that the p53-expressing OBP-702 is a promising antitumour reagent for human cancer and could improve the clinical outcome.
Yasumoto Yamasaki; Hiroshi Tazawa; Yuuri Hashimoto; Toru Kojima; Shinji Kuroda; Shuya Yano; Ryosuke Yoshida; Futoshi Uno; Hiroyuki Mizuguchi; Akira Ohtsuru; Yasuo Urata; Shunsuke Kagawa; Toshiyoshi Fujiwara
Related Documents :
10471607 - Prostacyclin enhances stretch-induced surfactant secretion in alveolar epithelial type ...
2284197 - Comparative studies of angiotensin ii and its analog [sar1ala8]angiotensin ii on the de...
10374767 - Congenital cystic adenomatoid malformation of the lung (ccam): evaluation of the cellul...
8238367 - Uptake of antioxidants in surfactant liposomes by cultured alveolar type ii cells is en...
23098467 - Crocetin induces cytotoxicity in colon cancer cells via p53- independent mechanisms.
15378647 - Basal prostate epithelial cells stimulate the migration of prostate cancer cells.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-13
Journal Detail:
Title:  European journal of cancer (Oxford, England : 1990)     Volume:  -     ISSN:  1879-0852     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9005373     Medline TA:  Eur J Cancer     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Ltd. All rights reserved.
Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Primary treatment and prognostic factors of small cell neuroendocrine carcinoma of the uterine cervi...
Next Document:  A DNA methylation signature associated with aberrant promoter DNA hypermethylation of DNMT3B in huma...